09 Sep 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 août 2022
|
10101015 Software |
Corporate life |
09 Sep 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of August 31st, 2022
|
10101015 Software |
Corporate life |
06 Sep 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies fera deux présentations concernant iCRO et iBiopsy® lors du congrès 2022 de l’ESMO du 9 au 13 septembre à Paris
|
10101015 Software |
Meetings / events |
06 Sep 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy®
|
10101015 Software |
Meetings / events |
03 Aug 2022
18:41 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2022
|
10101015 Software |
Legal |
03 Aug 2022
18:41 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 juillet 2022
|
10101015 Software |
Legal |
25 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies: Financial Communication Schedule for the Second Half of 2022
|
10101015 Software |
Legal |
25 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Calendrier de communication financière du second semestre 2022
|
10101015 Software |
Legal |
15 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Half Year Median Technologies Liquidity Contract Statement Contracted with TP ICAP
|
10101015 Software |
Legal |
15 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Bilan semestriel du contrat de liquidité
|
10101015 Software |
Legal |
11 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022
|
10101015 Software |
Income |
11 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies communique son niveau d’activité pour le premier semestre 2022
|
10101015 Software |
Income |
08 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies fera deux présentations concernant iBiopsy® lors de la conférence ECR 2022 (European Congress of Radiology) du 13 au 17 juillet à Vienne (Autriche)
|
10101015 Software |
Meetings / events |
08 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 juin 2022
|
10101015 Software |
Legal |
08 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy®
|
10101015 Software |
Meetings / events |
08 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30th, 2022
|
10101015 Software |
Legal |
07 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies fera un point d’avancement par webcast le 12 juillet 2022
|
10101015 Software |
Meetings / events |
07 Jul 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies to host a live webcast and provide a company update on July 12, 2022
|
10101015 Software |
Meetings / events |
13 Jun 2022
08:45 CEST |
MEDIAN TECHNOLOGIES |
Bryan Garnier & Co initie à l’achat la couverture de Median Technologies
|
10101015 Software |
Corporate life |
13 Jun 2022
08:45 CEST |
MEDIAN TECHNOLOGIES |
Bryan Garnier & Co Initiates the Coverage of Median Technologies with a “Buy” Recommendation
|
10101015 Software |
Corporate life |
08 Jun 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31st, 2022
|
10101015 Software |
Legal |
08 Jun 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mai 2022
|
10101015 Software |
Legal |
02 Jun 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA
|
10101015 Software |
New |
02 Jun 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies présentera un abstract à la conférence annuelle de l’ASCO, du 3 au 7 juin au McCormick Place, Chicago
|
10101015 Software |
New |
31 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials
|
10101015 Software |
New |
31 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies crée Imaging Lab, fer de lance pour intégrer les technologies de l’Intelligence Artificielle iBiopsy® dans les services iCRO d’imagerie pour les essais en oncologie
|
10101015 Software |
New |
23 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022
|
10101015 Software |
General meeting / Board Meeting |
23 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies annonce la mise à disposition des documents préparatoires à l’Assemblée générale ordinaire et extraordinaire du 14 juin 2022
|
10101015 Software |
General meeting / Board Meeting |
05 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies poursuit ses interactions avec la FDA pour son logiciel dispositif médical iBiopsy® Lung Cancer Screening CADe/CADx
|
10101015 Software |
Legal |
05 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
|
10101015 Software |
Legal |
03 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 avril 2022
|
10101015 Software |
Legal |
03 May 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2022
|
10101015 Software |
Legal |
21 Apr 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies publie ses résultats annuels 2021 et son niveau d’activité pour le premier trimestre 2022
|
10101015 Software |
Commercial results |
21 Apr 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
|
10101015 Software |
Commercial results |
08 Apr 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mars 2022
|
10101015 Software |
Legal |
08 Apr 2022
17:45 CEST |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2022
|
10101015 Software |
Legal |
25 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022
|
10101015 Software |
Legal |
25 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies avance la publication de ses résultats annuels 2021 au 21 avril 2022
|
10101015 Software |
Legal |
22 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance
|
10101015 Software |
New |
22 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies annonce avoir terminé la mise au point de son logiciel dispositif médical iBiopsy® Lung Cancer Screening CADe/CADx qui atteint des performances de sensibilité et de spécificité exceptionnelles
|
10101015 Software |
New |
10 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies répond aux conditions d’éligibilité du dispositif PEA-PME
|
10101015 Software |
Legal |
09 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 28 février 2022
|
10101015 Software |
Legal |
09 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of February 28th, 2022
|
10101015 Software |
Legal |
03 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
|
10101015 Software |
New |
03 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies dépose un dossier 513(g) auprès de la FDA pour son logiciel dispositif médical iBiopsy® Lung Cancer Screening CADe/CADx
|
10101015 Software |
New |
01 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies to Participate in the Cowen’s 42nd Annual Health Care Conference
|
10101015 Software |
Meetings / events |
01 Mar 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies participera à la 42ème conférence annuelle Health Care de Cowen
|
10101015 Software |
Meetings / events |
08 Feb 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of January 31st, 2022
|
10101015 Software |
Legal |
08 Feb 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 janvier 2022
|
10101015 Software |
Legal |
17 Jan 2022
17:45 CET |
MEDIAN TECHNOLOGIES |
Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million
|
10101015 Software |
Income |